1) Methotrexate-α-Phe
氨甲喋呤-α-苯丙氨酸
1.
The Solid-Phase Synthesis of Methotrexate-α-Phe~;
氨甲喋呤-α-苯丙氨酸的固相合成
2) Methotrexate
[英][,meθə'trekseit] [美][,mɛθə'trɛkset]
甲氨喋呤
1.
Preparation and in vitro Experimental Study of Methotrexate-Lactosyl-Chitosan Conjugate;
甲氨喋呤-乳糖酰基壳聚糖的制备及其体外实验
2.
Preparation and in Vitro Stability of Targeting Antitumor Drug: Methotrexate-Succinyl-Chitosan Conjugate;
靶向抗肿瘤药物甲氨喋呤-琥珀酰壳聚糖缀合物的制备及其体外稳定性的初步探讨
3.
Methotrexate effect tubal pregnancy in the conservative on surgical treatment;
甲氨喋呤在输卵管妊娠保守性手术治疗中的临床分析
3) MTX
甲氨喋呤
1.
Observation on Therapeutic Effect of Combination of San Wu Capsule and MTX on Rheumatoid Arthritis(RA);
三乌胶囊联合甲氨喋呤治疗类风湿性关节炎疗效观察
2.
Analysis of clinical effectiveness of nursing intervention in the treatment of ulcer of oral mucosa induced by using large dosage of methotrexate (MTX);
大剂量甲氨喋呤化疗诱发口腔黏膜溃疡护理干预临床效果分析
3.
Comparison of the Effect of Acitretin and MTX on Treating Psoriasis;
阿维A与甲氨喋呤治疗银屑病的疗效对比分析
4) Methotrexate(MTX)
甲氨喋呤
1.
To observe the clinical efficacy of Chinese medicines and small dose of Methotrexate(MTX) in the treatment of rheumatoid arthritis(RA), 72 cases were randomized into two groups: treatment group in which 32 cases were treated by Chinese medicines and small dose of MTX and control group in which 40 cases were treated by simple MTX.
探讨中药加服小剂量甲氨喋呤(MTX)治疗类风湿关节炎(RA)的疗效。
2.
The prepared micelles can be used as carriers of methotrexate(MTX),the drug-loading micelles released drug in PBS under the rule of Fick II diffusion model.
6 nm,符合载药胶束的要求;两亲性接枝聚天冬氨酸胶束对抗癌药物甲氨喋呤(MTX)具有一定的载药能力,其体外释药曲线符合F ick II扩散动力学模型。
5) methotrexate
[英][,meθə'trekseit] [美][,mɛθə'trɛkset]
氨甲喋呤
1.
Methotrexate management of fallopian pregnancy:Curative effect comparison of single-dose injection and multidose injection;
氨甲喋呤单次肌注与分次肌注治疗输卵管妊娠的疗效分析
2.
Combined use of methotrexate and mifepristone for ectopic pregnancy management:a meta-analysis;
氨甲喋呤联合米非司酮治疗异位妊娠的Meta分析
3.
The Solid-Phase Synthesis of Methotrexate-α-Phe~;
氨甲喋呤-α-苯丙氨酸的固相合成
6) MTX
氨甲喋呤
1.
Clinical Analysis of 68 Cases Ectopicgestation Treated with MTX and Ru 486;
应用氨甲喋呤与米非司酮治疗异位妊娠68例临床分析
2.
MTX Intramuscular Injection Treatment Different Location Pregnancy 38 Examples Analyses;
氨甲喋呤肌肉注射治疗异位妊娠38例分析
3.
Clinical observation of ultrasound-guided injection of MTX into uterine leiomyoma;
超声引导下注射氨甲喋呤治疗子宫肌瘤的临床疗效与血流变化观察
补充资料:氨甲叶酸
分子式:C20H22N8O5
分子量:454.46
CAS号:59-05-2
性质:橙黄色结晶性粉末。熔点185-204℃。易溶于稀碱、酸或碱金属的碳酸盐溶液,微溶于稀盐酸,几乎不溶于水、乙醇、氯仿、乙醚。
制备方法:由2,4,5,6-四氨基嘧啶与二溴丙醛环合后,再与对甲氨基苯甲酰谷氨酸缩合而得。
用途:该品是较好的抗肿瘤药物,用于急性淋巴白血病、淋巴瘤、恶性葡萄胎、绒癌、鳞状上皮癌、肺癌、宫颈癌、乳腺癌和成骨肉瘤等。甲氨喋呤口服12h后原药90%从尿中排出,主要代谢物为7-羟基甲氨蝶呤。大鼠静脉注射LD50为14mg/kg。
分子量:454.46
CAS号:59-05-2
性质:橙黄色结晶性粉末。熔点185-204℃。易溶于稀碱、酸或碱金属的碳酸盐溶液,微溶于稀盐酸,几乎不溶于水、乙醇、氯仿、乙醚。
制备方法:由2,4,5,6-四氨基嘧啶与二溴丙醛环合后,再与对甲氨基苯甲酰谷氨酸缩合而得。
用途:该品是较好的抗肿瘤药物,用于急性淋巴白血病、淋巴瘤、恶性葡萄胎、绒癌、鳞状上皮癌、肺癌、宫颈癌、乳腺癌和成骨肉瘤等。甲氨喋呤口服12h后原药90%从尿中排出,主要代谢物为7-羟基甲氨蝶呤。大鼠静脉注射LD50为14mg/kg。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条